Aptamers are high affinity molecules that are derived from RNA or DNA. These are normally generated using a synthetic process called “Systematic evolution of ligands by exponential enrichment” (SELEX).
The global aptamers market is poised for rapid growth between 2018 and 2025. Factors such as strong trend of R&D investments in biotechnology and pharmaceutical industries, the patent expiration of systematic evolution of ligands by exponential enrichment technology (SELEX), technological advancements, and the low cost and high efficiency of aptamers in binding to large molecules as compared to antibodies are driving the growth of the aptamers market.
Market Analysis and Insights: Global Aptamers Market
The global Aptamers market is valued at US$ 56 million in 2019. The market size will reach US$ 128.3 million by the end of 2026, growing at a CAGR of 12.5% during 2021-2026.
Global Aptamers Scope and Market Size
Aptamers market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Aptamers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.
Segment by Type
DNA-Based Aptamers
RNA-Based Aptamers
Segment by Application
Research and Development
Drug Discovery
By Company
TriLink BioTechnologies
AptaBharat
SomaLogic
AM Biotechnologies
Aptamer Sciences
Base Pair Biotechnologies
Aptamer Group
Aptagen
Aptus Biotech
NeoVentures Biotechnology
Ray Biotech
Vivonics
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
The global aptamers market is poised for rapid growth between 2018 and 2025. Factors such as strong trend of R&D investments in biotechnology and pharmaceutical industries, the patent expiration of systematic evolution of ligands by exponential enrichment technology (SELEX), technological advancements, and the low cost and high efficiency of aptamers in binding to large molecules as compared to antibodies are driving the growth of the aptamers market.
Market Analysis and Insights: Global Aptamers Market
The global Aptamers market is valued at US$ 56 million in 2019. The market size will reach US$ 128.3 million by the end of 2026, growing at a CAGR of 12.5% during 2021-2026.
Global Aptamers Scope and Market Size
Aptamers market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Aptamers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.
Segment by Type
DNA-Based Aptamers
RNA-Based Aptamers
Segment by Application
Research and Development
Drug Discovery
By Company
TriLink BioTechnologies
AptaBharat
SomaLogic
AM Biotechnologies
Aptamer Sciences
Base Pair Biotechnologies
Aptamer Group
Aptagen
Aptus Biotech
NeoVentures Biotechnology
Ray Biotech
Vivonics
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.